In Situ Vaccination with Poly-ICLC Combined with Systemic Nivolumab for the Treatment of Unresectable Hepatocellular Carcinoma

In Situ Vaccination with Poly-ICLC Combined with Systemic Nivolumab for the Treatment of Unresectable Hepatocellular Carcinoma

Ja-Der Liang,1 Po-Chin Liang,2,3 Chia-Tung Shun,4 Chien-Hung Chen,1,5 Yao-Ming Wu,6,7 Yu-Chen Hsu,4,8 Ying-Te Lee,4 Pei-Ming Yang,1,4 Guan-Tarn Huang,1,9 Andres M Salazar,10 Hsuan-Shu Lee,1,4 Jin-Chuan Sheu,1,4 Meng-Tzu Weng1,11 1Department of Internal Medicine, National Taiwan University Hospital a...

Full description

Saved in:
Bibliographic Details
Main Authors: Liang JD, Liang PC, Shun CT, Chen CH, Wu YM, Hsu YC, Lee YT, Yang PM, Huang GT, Salazar AM, Lee HS, Sheu JC, Weng MT
Format: Article
Language:English
Published: Dove Medical Press 2025-06-01
Series:Journal of Hepatocellular Carcinoma
Subjects:
Hepatocellular carcinoma
Poly-ICLC
In situ vaccination
immune checkpoint inhibitors
Portal vein thrombus
Digital spatial profiling.
Online Access:https://www.dovepress.com/in-situ-vaccination-with-poly-iclc-combined-with-systemic-nivolumab-fo-peer-reviewed-fulltext-article-JHC
Tags: Add Tag
No Tags, Be the first to tag this record!
Login for hold and recall information

Internet

https://www.dovepress.com/in-situ-vaccination-with-poly-iclc-combined-with-systemic-nivolumab-fo-peer-reviewed-fulltext-article-JHC

Similar Items